Effusion Lymphoma
📧 Sign up to get email alerts when something new happens for Effusion Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating lenalidomide in combination with modified DA-EPOCH and rituximab (EPOCH-R2) for primary effusion lymphom…
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas [Phase 1, Phase 2]
Clinical trial evaluating vorinostat in combination with chemotherapy and rituximab for HIV-related and other aggressive B-cell lymphomas; t…
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas [Phase 2]
Phase 2 trial of pegylated liposomal doxorubicin (Doxil) with rituximab for relapsed AIDS-related non-Hodgkin lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion Lymphoma [Phase 2]
A Phase 2 study of Bortezomib with antiviral therapy followed by effusion drainage, Bevacizumab, and combination chemotherapy for primary ef…